Lv1
60 积分 2024-08-27 加入
KRAS mutation-driven O-GlcNAcylation of CLDN18.2 enhances the progression of pancreatic cancer and reduces the efficacy of CLDN18.2-targeted therapy
5个月前
已完结
The deubiquitinase OTUD1 orchestrates cisplatin chemosensitivity of non-small cell lung cancer through destabilizing RAD23B/XPC
5个月前
已完结
Engineered bacteria for near-infrared light-inducible expression of cancer therapeutics
7个月前
已完结
皖公网安备34019202002308
